What are the two specific reversal agents discussed in this context?
The two specific reversal agents discussed in this context are Idarucizumab and Andexanet Alfa. Idarucizumab is a humanized monoclonal antibody fragment developed as a specific reversal agent for dabigatran, and Andexanet Alfa is a specific reversal agent for direct (apixaban, rivaroxaban, and edoxaban) and indirect (low-molecular-weight heparins [LMWHs] and fondaparinux) factor Xa inhibitors that act through antithrombin.